Otherwise, no interactions between baseline WMH volume and CSF Aβ42 and p-tau levels were found, with respect to the time to symptom onset [48], suggesting that cerebral SVD and AD pathologies have substantially independent effects on the risk of progression to MCI. Here, MAPT is linked to Alzheimer disease.